Therapeutic vaccination for chronic diseases: a new class of drugs in sight.
Bachmann
Martin F
MF
Cytos Biotechnology AG, Wagistr 25, Schlieren-Zürich, Switzerland. martin.bachmann@cytos.com
Dyer
Mark R
MR
D000911:Antibodies, Monoclonal / Q000009:adverse effects / Q000627:therapeutic use; D002908:Chronic Disease / Q000628:therapy*; D006801:Humans; D007167:Immunotherapy / Q000009:adverse effects / Q000379:methods; D055502:Secondary Prevention; D014612:Vaccines / Q000009:adverse effects / Q000627:therapeutic use
D000911:Antibodies, Monoclonal; D014612:Vaccines